Clinical Trial

Effect of Nutritional Supplement Alpha-ketoglutarate for Age-related Ocular Disease

Study acronym: OAK AGE
Completed Early Phase 1
View on ClinicalTrials.gov →
Summary
The aims of the study are as follows: 1. Determine how the eye absorbs supplements taken orally. 2. Look for specific signs in the proteins and substances in the eyes of people with eye diseases who are also taking nutritional supplements.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-25.
Trial Details
NCT Number NCT07269704
Lead Sponsor Stanford University
Conditions Eye Diseases
Enrollment 17 participants
Start Date 2023-08-15
Primary Completion 2025-06-10 (estimated)
Study Completion 2025-06-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-03